FindTrial
Sign In

Pharmacotherapy and Intensive Treatment of Drug Abuse - 1

Pharmacotherapy and Intensive Treatment of Drug Abuse

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00000217
Enrollment
Unknown
Registered
1999-09-21
Start date
1990-09-30
Completion date
Unknown
Last updated
2015-04-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cocaine-Related Disorders, Substance-Related Disorders

Keywords

drug abuse

Brief summary

The purpose of this study is to evaluate desipramine and carbamazepine in reducing cocaine craving; increase outpatient treatment capacity and evaluate their incidence of psychiatric disorders.

Interventions

DRUGCarbamazepine

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
US Department of Veterans Affairs
CollaboratorFED
University of Kansas
Lead SponsorOTHER

Study design

Primary purpose
TREATMENT

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

Please contact site for information.

Design outcomes

Primary

MeasureTime frame
Drug use—
Effectiveness of medication—
Level of pharm—
Retention—
Depression, anxiety—

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026